News - Tropical diseases, Markets & Marketing


Popular Filters

Eisai gains WHO prequalification for DEC; launches high-dose Aricept in Korea


Japanese drug major Eisai (TYO: 4523) has received prequalification from the World Health Organization…

AriceptAsia-PacificdiethylcarbamazineEisaiMarkets & MarketingNeurologicalPharmaceuticalRegulationTropical diseases

Eisai's Fycompa gets first EU launch, in UK; links with Sabine Vaccine Inst


Japanese drug major Eisai (TYO: 4523) has announced the first European launch today of Fycompa (perampanel),…

EisaiFycompaMarkets & MarketingNeurologicalPharmaceuticalResearchTropical diseasesVaccines

Ranbaxy debuts first Indian-developed malaria drug, Synriam


Indian drug major Ranbaxy (AB: B) said yesterday - coinciding with World Malaria Day - that it is "opening…

Asia-PacificDaiichi SankyoMarkets & MarketingPharmaceuticalRanbaxy LaboratoriesSynriamTropical diseases

Fake drugs dashing hopes of controlling malaria in Africa


The emergence of fake and poor quality anti-malarial drugs could dash hopes of controlling malaria in…

GenericsMarkets & MarketingPharmaceuticalRest of the WorldTropical diseases

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top